Skip to main content
Citadel Group logo

Citadel Group — Investor Relations & Filings

Ticker · CGL ISIN · AU000000CGL3 LEI · 213800FIHTDHRZIC4882 ASX Financial and insurance activities
Open in API
Filings indexed 2,090 across all filing types
Latest filing 2023-01-25 M&A Activity
Country AU Australia
Listing ASX CGL

About Citadel Group

https://www.citadelgroup.com.au/

Citadel Group is a software and technology company specializing in secure enterprise information management for complex environments. The firm develops and delivers software applications, digital platforms, managed services, and IT solutions. It primarily serves government departments and large corporate clients, with a focus on managing system-critical data. The company also provides solutions for the healthcare sector aimed at improving patient outcomes. The organization has evolved and now operates under the name Citadel Edge.

Recent filings

Filing Released Lang Actions
Form 8.3 -Horizon Therapeutics plc
M&A Activity Classification · 95% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997. This form is used for 'Opening Position Disclosure/Dealing Disclosure' by persons with interests in relevant securities representing 1% or more during a takeover or merger situation. This falls under the category of Major Shareholding Notification (MRQ) as it reports significant share ownership and changes in positions related to a takeover offer.
2023-01-25 English
Form 8.3 - Mediclinic International plc
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the UK Takeover Code when a person or entity holds 1% or more of a company's securities during an offer period. It details shareholdings, derivatives, and recent dealings. This type of disclosure is a specific regulatory requirement for major shareholders or parties involved in M&A activity, and it is filed via a Regulatory Information Service (RNS). Since it is a specific regulatory disclosure form rather than a general announcement or a report, it falls under the 'Regulatory Filings' category.
2023-01-25 English
Form 8.3 - Mediclinic International plc
Regulatory Filings Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree. It details share dealings, positions, and derivative transactions. Since it is a specific regulatory disclosure form and not a general announcement or a report, it falls under the 'Regulatory Filings' category.
2023-01-24 English
Form 8.3 -Horizon Therapeutics plc
Major Shareholding Notification Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the Irish Takeover Panel Act. It details the interests and short positions of Citadel Group in the securities of Horizon Therapeutics PLC. This type of filing is a mandatory disclosure of major shareholding and derivative positions during a takeover or merger process. While it relates to M&A activity, it is specifically a 'Major Shareholding Notification' (MRQ) regarding the crossing of thresholds or disclosure of positions during an offer period, rather than a general M&A announcement (TAR).
2023-01-24 English
Form 8.3 - Mediclinic International plc
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. It details shareholdings, derivative positions, and recent dealings. Since this is a specific regulatory disclosure regarding major shareholdings and takeover-related activity that does not fit into the other specific categories like 'Major Shareholding Notification' (which usually refers to TR-1 filings) or 'M&A Activity' (which refers to the corporate deal itself), it is best classified as a Regulatory Filing (RNS).
2023-01-23 English
Form 8.3 -Horizon Therapeutics plc
Major Shareholding Notification Classification · 96% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the Irish Takeover Panel Act. It details the interests and short positions of a person (Citadel Group) in the relevant securities of an offeror/offeree (Horizon Therapeutics PLC) during a takeover process. This type of disclosure is a specific regulatory requirement for major shareholding and dealing activity during M&A events, fitting the 'Major Shareholding Notification' category.
2023-01-20 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.